Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Zhongzhi Pharmaceutical Holdings Limited ( (HK:3737) ) just unveiled an update.
Zhongzhi Pharmaceutical Holdings Limited has announced its upcoming annual general meeting scheduled for May 13, 2025, in Hong Kong. Key agenda items include the approval of the 2024 financial statements, a final dividend payment, the re-election of directors, and the reappointment of Ernst & Young as auditors. Additionally, the company seeks shareholder approval for a share repurchase program, allowing the purchase of up to 10% of its issued shares, which could impact its stock market performance and shareholder value.
More about Zhongzhi Pharmaceutical Holdings Limited
Zhongzhi Pharmaceutical Holdings Limited is a company incorporated in the Cayman Islands, operating within the pharmaceutical industry. The company is listed on the Stock Exchange of Hong Kong and is involved in the development and distribution of pharmaceutical products.
YTD Price Performance: -9.09%
Average Trading Volume: 304,879
Technical Sentiment Signal: Buy
Current Market Cap: HK$762.3M
For detailed information about 3737 stock, go to TipRanks’ Stock Analysis page.